REDUCE-AMI Trial: Diminishing Role of Beta-Blockers in ACS with preserved LVEF

REDUCE-AMI Trial: Diminishing Role of Beta-Blockers in ACS with preserved LVEF

1. The REDUCE-AMI trial showed no significant benefit of beta-blockers in reducing all-cause mortality or future myocardial infarction in patients with acute myocardial infarction and preserved left ventricular ejection fraction.

2. The trial included 5,020 patients who were randomized to either beta-blockade with metoprolol or bisoprolol or usual care, with follow-up over a median of 3.5 years.

3. Primary and secondary outcomes showed no significant differences between the beta-blocker and usual care groups.

4. Safety outcomes were similar between groups, and there was significant crossover and varying adherence to beta-blocker therapy over time.

5. The findings suggest a need to re-evaluate the routine use of beta-blockers in this patient population, emphasizing personalized treatment approaches and further research.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(35)

Improving Left Ventricular Ejection Fraction in Heart Failure Patients: Insights from the HF-OPT Study

Improving Left Ventricular Ejection Fraction in Heart Failure Patients: Insights from the HF-OPT Study

The HF-OPT study investigated the improvement of left ventricular ejection fraction (LVEF) beyond 90 days in patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF). In this...

22 Kesä 20245min

AI in Cardiovascular Medicine: JACC Review

AI in Cardiovascular Medicine: JACC Review

Overview: This review discusses the use and future directions of AI in cardiology, focusing on areas like electrocardiography, telemetry and wearables, echocardiography, CMR, nuclear cardiology, CT, e...

21 Kesä 20246min

2024 ACC Peripheral Artery Disease (PAD) Guidelines

2024 ACC Peripheral Artery Disease (PAD) Guidelines

Collaborative vascular care is emphasized to address health disparities, gaps in medical therapy, structured exercise, and good foot care along with appropriate revascularization to prevent limb loss....

31 Touko 20246min

2024 ACC/AHA Guidelines on Hypertrophic Cardiomyopathy

2024 ACC/AHA Guidelines on Hypertrophic Cardiomyopathy

2024 HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Mavacamten: Class 1 recommendation for symptomatic obstructive HCM. Exercise: Now allows for "vigorous" activity; competitive lev...

21 Touko 20249min

DOACs: When direct oral anticoagulants should not be used?

DOACs: When direct oral anticoagulants should not be used?

Key Points: Positive Aspects of DOACs: DOACs are acknowledged for their convenience, efficacy, and safety in conditions like atrial fibrillation (AF) and venous thromboembolism (VTE). The review sup...

29 Tammi 20244min

Cath: NPO vs Eating before Heart Cath

Cath: NPO vs Eating before Heart Cath

Background: Traditional practice requires fasting before cardiac catheterization, but there's no evidence to support it. Objective: This study compared a heart-healthy pre-procedure diet with fasting ...

26 Tammi 20243min

Stable CAD and Angina: PCI without medical therapy as first treatment (ORBITA-2)

Stable CAD and Angina: PCI without medical therapy as first treatment (ORBITA-2)

Key Points In patients not taking antianginal meds, PCI alleviated some—but not all—symptoms Background: Percutaneous coronary intervention (PCI) is commonly used to alleviate stable angina symptom...

22 Tammi 20243min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
psykopodiaa-podcast
terapiassa
meditaatiot-suomeksi
rss-pitaisko-erota
rss-seksicast
fitnessvastaanotto
paritellen
rss-kuumilla-aalloilla
junnut-pelissa
rss-pt-paahtio
rss-uplevel-by-sonja-hannus
selviytyjat-tarinoita-elamasta
rss-vapaudu-voimaasi
kehorauhaa
rss-rentoudu-podcast-rentoutumiseen-hanna-viljanmaa
onnen-kuplia
rss-sanelunpurku-podcast